Video

National Blood Donor Month: Incentivizing Donations and Meeting Supply Needs

Author(s):

Encouraging and incentivizing donations is essential to ensuring supplies of all blood types are met.

A key challenge faced by blood suppliers—such as the American Red Cross—is ensuring supply demands of all blood types are met. Of course, one factor of the solution stems from encouraging individuals to donate blood.

And yet, barriers such as reticence can prevent or discourage one from doing so.

“The number one reason that people give as to why they’ve never donated is that they’ve never been asked to donate,” Rodney Wilson, Senior Biomedical Communications Specialist of American Red Cross, tells HCPLive® in an interview

“Most people don’t even realize this is a daily need,” he continued.

He explained the importance of working through community organizations and leveraging familiarity within communities. In particular, members within the community volunteering with the Red Cross can encouraging participation through direct and personal communication with neighbors.

“We find that the personal ask ultimately makes a big difference,” Wilson said. “When people realize that there is a need and get a specific ask from someone they know, they seem very willing to do it.”

Wilson also discussed the Red Cross’s offering of coronavirus disease 2019 (COVID-19) antibody tests, another strategy that has particularly garnered a degree of interest among potential donors.

Beyond simply informing donors of their prior COVID-19 status, the donation process can benefit those ill with the virus through use of donor convalescent plasma.

Related Videos
Françoise Bernaudin, MD: A Decade of Follow-up Reveals allo-SCT Superiority Over SOC for Sickle Cell Anemia
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Christine N. Kay, MD | Image Credit: Atsena Therapeutics
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
Roger A. Goldberg, MD: Pooled Visual Function Data of NT-501 for MacTel | Image Credit: Bay Area Retina Associates
Signs and Symptoms of Connective Tissue Disease
© 2024 MJH Life Sciences

All rights reserved.